Ali AH, et al. - Authors attempted to inspect if surveillance was associated with better survival after diagnosis of hepatobiliary cancers (HBCa) in patients with primary sclerosing cholangitis (PSC). They appraised medical records of PSC patients seen at the Mayo Clinic Rochester from 1995 to 2015. It was deduced that patients in the surveillance group exhibited considerably higher 5 year overall survival and a markedly lower 5 year probability of experiencing an HBCa-related adverse event compared with the no-surveillance group. The inference drawn was that HBCa surveillance greatly improved the outcomes, including survival, in patients with PSC.